ROGELIO ORTIZ: Open Payments
NPI 1346950292 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$48 in 2 payments from 2 companies in 2025. Trend: 2023 $192 · 2024 $26 · 2025 $48
Food & beverage: $48
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: GLASSIA, JASCAYD.
Industry payments across TX — which companies pay providers there.
